Molecule
Tobramycin is an aminoglycoside antibacterial indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. It is available as inhalation solution, eye drops and injection for ophthalmic and intravenous use. MedsAcross supplies Tobramycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
TOBREX ® (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. Appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of TOBREX (tobramycin ophthalmic ointment) 0.3%. Clinical studies have shown tobramycin to be safe and effective for use in children.
Source: US FDA prescribing information
In mild to moderate disease, apply a half-inch ribbon into the affected eye(s) 2 or 3 times per day. In severe infections, instill a half-inch ribbon into the affected eye(s) every 3 to 4 hours until improvement, following which treatment should be reduced prior to discontinuation. How to Apply TOBREX (tobramycin ophthalmic ointment) 0.3%: 1. Tilt your head back. 2. Place a finger on your cheek just under your eye and gently pull down until a ''V'' pocket is formed between your eyeball and your lower lid. 3. Place a small amount (about ½ inch) of TOBREX ® (tobramycin ophthalmic ointment) 0.3% in the ''V'' pocket. Do not let the tip of the tube touch your eye. 4. Look downward before closing your eye.
Source: US FDA prescribing information
TOBREX (tobramycin ophthalmic ointment) 0.3 % is contraindicated in patients with known hypersensitivity to any of its components.
Source: US FDA prescribing information
NOT FOR INJECTION INTO THE EYE. Sensitivity to topically applied aminoglycosides may occur in some patients. Severity of hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching, urticaria, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If a sensitivity reaction to TOBREX (tobramycin ophthalmic ointment) 0.3% occurs, discontinue use.
Source: US FDA prescribing information
The most frequent adverse reactions to TOBREX (tobramycin ophthalmic ointment) 0.3% are hypersensitivity and localized ocular toxicity, including lid itching and swelling, and conjunctival erythema. These reactions occur in less than three of 100 patients treated with TOBREX ® (tobramycin ophthalmic ointment) 0.3%. Postmarketing Experience: Additional adverse reactions identified from postmarketing use include anaphylactic reaction, Stevens-Johnson syndrome, and erythema multiforme. The following additional adverse reactions have been reported with systemic aminoglycosides: Neurotoxicity, ototoxicity and nephrotoxicity have occurred in patients receiving systemic aminoglycoside therapy.
Source: US FDA prescribing information
Store at 2°C to 25°C (36°F to 77°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
16 presentations of Tobramycin, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tobramycin 3 mg/mL eye dropsOphthalmicGeneric name | — | US FDA | Available on request |
| Tobramycin 1.2 g/30 mL powder for injectionIntravenousGeneric name | — | US FDA | Available on request |
| Tobramycin 300 mg/5 mL inhalation solutionInhalation Cold chainGeneric name | — | US FDA | Available on request |
| Tobramycin 3 mg/mL ophthalmic solutionOphthalmicGeneric name | — | US FDA | Available on request |
| Tobramycin 80 mg/2 mL injectionIntramuscular, intravenousGeneric name | — | US FDA | Available on request |
| Tobramycin 1200 mg/30 mL injectionIntramuscular, intravenousGeneric name | — | US FDA | Available on request |
| Tobramycin 300 mg/4 mL inhalation solutionInhalation Cold chainGeneric name | — | US FDA | Available on request |
| Tobramycin 300 mg/5 mL inhalantInhalation Cold chainGeneric name | — | US FDA | Available on request |
| Bethkis 300 mg/4 mL inhalation solutionInhalation Cold chain | Chiesi | US FDA | Available on request |
| Tobramycin 20 mg/2 mL injectionIntramuscular, intravenousGeneric name | — | US FDA | Available on request |
| Kitabis Pak 300 mg/5 mL inhalation solutionInhalation Cold chain | Pari Respiratory Equipment | US FDA | Available on request |
| Tobi 300 mg/5 mL inhalation solutionInhalation, oral Cold chain | Viatris Specialty | US FDA | Available on request |
| TOBI Podhaler 28 mg inhalation capsuleInhalation, oral | Viatris Specialty | US FDA | Available on request |
| Tobramycin 2000 mg/50 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Tobramycin Inhalation Solution Pak 300 mg/5 mL inhalation solutionInhalation Cold chain | Genericus | US FDA | Available on request |
| Tobrex 0.3% eye ointmentOphthalmic | Novartis Pharmaceuticals | US FDA | Available on request |
6 brand names across 1 markets.
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions linked to Tobramycin in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 16 presentations of Tobramycin and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 6 brand names for Tobramycin, including Bethkis, Kitabis Pak, Tobi, TOBI Podhaler, Tobramycin Inhalation Solution Pak, Tobrex.
Yes. The US FDA first approved Tobramycin on 11 June 1975, according to Drugs@FDA.
Yes. Tobramycin has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
At least one listed presentation of Tobramycin must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.
Tobramycin is classified under ATC code J01GB01 (Tobramycin).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.